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Executive summary 
The Task Force on Health Systems Research was set up by WHO at the end of 
2003 to develop a research agenda to support the attainment of the Millennium 
Development Goals.  
The Task Force report notes that: 
• Health system constraints constitute major barriers to achieving the 
MDGs. 
• There are many unanswered questions about how to strengthen health 
systems and scale-up effective interventions.  
• More resources are needed to answer these questions and build capacity 
within less-developed countries.  
After wide consultation the Task Force suggests that in order to generate the 
knowledge to strengthen health systems and achieve the MDGs, research on 
health systems should address the 12 topic areas outlined in the appendix. 
The Task Force also recommends that WHO should: 
• concentrate currently available resources for health systems research on 
high priority projects in order to ensure adequate funding for 
methodologically sound investigations; 
• secure funds to evaluate the implementation of its major programmes and 
to address cross-cutting problems within national health systems that limit 
the potential for success of all of these initiatives;  
• ensure a coordinated and adequately resourced ongoing effort to identify 
and address emerging needs for health systems research across clusters 
and programmes; 
• promote the compilation and use of systematic reviews of topics relevant 
to health systems;  
• support member countries to take coordinated action to strengthen health 
systems research within and across countries by building research 
capacity and developing collaborative networks; 
• facilitate the development of effective mechanisms to promote the uptake 
of research findings by national and international policy makers;  
• assess the feasibility of establishing a special programme on health 
systems research; and  
• monitor progress towards the achievement of these recommendations 
through the WHO Advisory Committee on Health Research. 
Report of the Task Force on Health Systems Research 3
Introduction 
In 2000, 189 countries signed the United Nations Millennium Declaration. The 
document includes eight Millennium Development Goals (MDGs) with specific 
targets for poverty eradication and development that are to be achieved by 
2015.1 Three of the eight MDGs are directly related to health: reducing child 
mortality; improving maternal health; and combating HIV/AIDS, malaria, and 
other diseases (Table 1). Health also underpins many of the other MDGs, 
primarily because poverty is a potent cause of ill-health, but also because illness 
can lead to poverty as a result of loss of income and/or catastrophic health 
expenditures.2  
The ambitious nature of these goals, along with concerns about the massive 
health challenges facing the world’s poorest countries, has led to a growing 
momentum within the field of global health. This has included a series of high-
profile global health initiatives such as the Global Fund to Fight AIDS, 
Tuberculosis and Malaria, Stop TB, Roll Back Malaria, the 3x5 programme 
(which aims to ensure that three million HIV-positive people are receiving 
treatment with antiretrovirals by the end of 2005), the US President’s Emergency 
Plan for AIDS Relief (PEPFAR), and the Global Alliance for Vaccines and 
Immunization (GAVI).  
Recent evidence, however, suggests that many low-income countries are 
unlikely to achieve the MDG health targets by 20153,4 and that those countries 
furthest away from the targets are least likely to make significant progress. Even 
though the number of effective and affordable interventions is growing and 
international assistance in the form of billion-dollar funds for specific diseases is 
increasing, this is still inadequate. Around $30 billion annually would be needed  
 
 
Table 1 The Millennium Development Goals 
Goal 1: Eradicate extreme poverty and hunger 
Goal 2: Achieve universal primary education 
Goal 3: Promote gender equality and empower women 
Goal 4: Reduce child mortality 
Goal 5: Improve maternal health 
Goal 6: Combat HIV/AIDS, malaria, and other diseases 
Goal 7: Ensure environmental sustainability 
Goal 8: Develop a global partnership for development 
For a full list of MDGs, their targets and indicators, see http://unstats.un.org/unsd/mi/mi_goals.asp
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from donors by 2007 to enable the poorest countries to deliver essential health 
services. This is equivalent to around 0.1% of donor country income and could 
therefore easily be achieved by increasing current Overseas Development 
Assistance from 0.25% of GNP to the target level of 0.7%.5 Low-income 
countries also need to allocate more of their national budgetary revenues to the 
health sector. The WHO Commission on Macroeconomics and Health called for 
an increase of 1% of GNP in annual health spending in public sector budgets by 
2007.6  
Increased resources for health are essential but in addition there is a growing  
consensus that “a primary bottleneck to achieving the MDGs in low-income 
countries is health systems that are too fragile and fragmented to deliver the 
volume and quality of services to those in need”.7 Although further basic research 
is needed to develop better interventions, the full implementation of existing 
interventions would, for example, reduce child mortality by around two thirds8 
(Figure 1) and maternal mortality by around three quarters.3  
Many of the barriers to scaling up effective interventions are common to a range 
of global programmes addressing priority health problems. Reviews of 
programmes focused on child health, maternal health, HIV/AIDS, malaria, and 
tuberculosis in a range of countries have identified a number of health system 
challenges to delivering effective and affordable interventions, including:*  
• lack of demand for the interventions at the individual and community level; 
• policies that do not support the use of effective and affordable drugs; 
• multiple uncoordinated actors (public and private sectors) who have 
different priorities and modes of working; 
• underdeveloped service management capacity; 
• competition between programmes; 
• inefficiency and/or inequity in financing and resource allocation; 
• weak health information systems; and 
• limited availability and suboptimal performance of human resources.  
At the same time, the many health policies and approaches to organizing and 
delivering services have not been adequately evaluated, and so the evidence 
base for strengthening health systems in low-income settings is weak.  
This knowledge deficit about how best to strengthen health systems in resource-
poor settings prompted Dr Tim Evans, Assistant Director General of WHO, to 
convene the Task Force on Health Systems Research. Its primary aim was to 
develop an agenda for health systems research, which if addressed, would 
support the attainment of the MDGs.  
 
                                                 
* for a more detailed discussion of challenges see reference 7 
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Figure 1 Comparison of child deaths that are preventable and not 
preventable with existing health interventions 8 
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The process of developing a research agenda 
The Task Force met on two occasions: in December 2003, during the Global 
Forum for Health Research Conference in Geneva, and again in November 2004 
in Mexico City, during the Ministerial Summit on Health Research and the Global 
Forum for Health Research conference. The Task Force’s membership and the 
names of those who contributed to its work are listed at the end of this report.  
Previous approaches to priority setting in health research were reviewed for their 
applicability to health systems research. The Ad Hoc Committee on Health 
Research developed a five-step process for research priority setting9 and there 
have been a number of subsequent approaches focusing particularly on specific 
diseases, for example, using epidemiological data on the burden of disease.10 
But because health systems underpin the effective prevention and care of a 
range of health problems, the development of a research agenda poses 
particular challenges. It has been suggested that in these circumstances, 
interpretive approaches based on the consensus views of informed participants 
may be attractive because of “their ability to juggle multiple assumptions and 
objectives”.11  
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Of course, a number of stakeholders have legitimate perspectives on what is 
important, including policy makers, health personnel, and civil society. As a 
result, the Task Force was asked to consult widely with this diverse group of 
stakeholders to elicit their opinions about the new knowledge required to 
strengthen health systems and attain the MDGs. 
The Task Force’s thinking was influenced by analyses of health systems 
constraints to achieving the MDGs7,12,13 and previous work aimed at identifying 
priority research topics on health systems.14 With inputs from WHO staff and 
other experts, a tentative research agenda was developed comprising 12 topic 
areas that were intended to cover the important barriers to improving health 
systems performance (see Table 2).  
Improved knowledge in each of these topic areas could contribute particularly to 
the attainment of the MDGs directly related to health but also to the attainment of 
the other MDGs (see Table 1). The relationships are complex because each goal 
can be affected by a range of factors interacting both directly and indirectly with 
health. For example, improvements in the health of women and girls could 
reduce gender disparities in education (MDG 3).15
The Task Force then undertook a consultative process involving several WHO 
regional meetings, an article in The Lancet,15 a presentation at the Ministerial 
Summit in Health Research in Mexico,16 and the extensive circulation of the 
preliminary research agenda using e-mail discussion lists. Reflecting the 
feedback that was received throughout the consultative process, brief templates 
were prepared for each proposed topic (see the appendix). They address the 
following questions: 
• What is the problem and why is it important? 
• What is known and what is not known? 
• What research is needed and how would it help? 
 
In the remainder of this report we focus on a few broader issues that should 
apply to all health systems research and that are essential to factor into any 
attempt to move the health systems research agenda forward—equity, 
systematic reviews, methodology, networking, funding, and evaluation.   
 
The central importance of equity 
The “inverse care law”, initially put forward over 30 years ago, still applies today: 
“the availability of good medical care tends to vary inversely with the need to it in 
the population served”.17 The MDGs address inequities between nations but 
there are also major health inequities within nations that need to be addressed.  
For example, in a recent review of 56 developing countries, death rates were 
nearly twice as high, on average, among infants and children in the bottom  
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Table 2 Suggested topics for health systems research 
Financial and human resources: 
Community-based financing and national health insurance 
Human resources for health at the district level and below 
Human resources for health at the national level 
Organization and delivery of health services: 
Community involvement 
Equitable, effective and efficient health care 
Approaches to the organisation of health services 
Drug and diagnostic policies 
Governance, stewardship, and knowledge management: 
Governance and accountability 
Health information systems 
Priority setting and evidence-informed policy making 
Effective approaches for intersectoral engagement in health 
Global influences: 
Effects of global initiatives and policies (including trade, donors, and 
international agencies) on health systems 
 
  
 
 
economic quintile of the population compared with the wealthiest 20%.18 The 
opposite trend was found in disparities with respect to access to health 
systems—the better-off generally fared far better than the disadvantaged. 
Gender is also a significant contributing factor to inequities in health within many 
nations both because health systems may not deliver services appropriately to 
cater for the needs of women and because women suffer more from the effects 
of poverty in many societies.  
Any health systems research agenda, therefore, needs to address explicitly how 
to reduce the socioeconomic differentials in access to effective health care, 
which may be compounded by political and cultural factors. In recognition of the 
central role of primary health care in achieving the MDGs by reaching vulnerable 
and disadvantaged populations, many of the priority topics have a strong focus 
on the research that is required (at the global, national, and local level) to 
strengthen this central component of health systems in low- and middle-income 
countries. 
Report of the Task Force on Health Systems Research 8
For a further discussion on equity, gender, health, and research we refer readers 
to “Priorities for research to take forward the health equity policy agenda”, 
published in October 2004 by the WHO Task Force on Health System Research 
Priorities for Equity in Health (see www.who.int/rpc/meetings/en/). In addition, the 
People’s Health Movement has developed an agenda for global health research 
that aims to reduce health and heath-care inequities.19 Both complement our 
report, which covers a wide range of health system topics. Moreover, the WHO 
has recently launched the Commission on Social Determinants of Health, which 
has a mission to act upon the social and environmental causes of health 
inequities and increase vulnerable people's chances for a healthy life. Our report, 
therefore, does not attempt to encompass research on the determinants of health 
in a comprehensive fashion and only includes research questions on how the 
health system can more effectively engage with other sectors to improve health. 
 
More systematic reviews required 
Although more primary research is clearly needed to fill in the knowledge gaps 
that are highlighted in the 12 templates, it is also essential to map out the 
relevant research that has already been undertaken. Systematic reviews of each 
of the topic areas are a necessary prerequisite to commissioning new research 
and will ensure there is no unnecessary duplication of pre-existing work. By 
synthesizing all relevant existing knowledge, a systematic review reduces bias 
and the role of chance, and thus provides a more precise estimate of the strength 
of the evidence. 
More high-quality systematic reviews of topics relevant to health systems in the 
developing world are required. Only a few of the reviews that have been 
completed by the Cochrane Collaboration’s Effective Practice and Organisation 
of Care group20 are from low- and middle-income countries; and although their 
numbers have been rising, in 2003 only 8.2% the Cochrane Collaboration’s 
reviewers were from developing countries.21  
There are a number of challenges in undertaking reviews of health systems 
topics, including the publication of many reports in the grey literature; the 
frequent lack of clear descriptions of complex interventions; and the frequent 
changes to the governance, financial, and delivery arrangements within which 
interventions are delivered. Nevertheless, they can provide useful information for 
researchers and policy makers and should be supported by donors, international 
agencies, and national governments.  
 
Making research valid and transferable 
Rigorous health systems research requires contributions from many disciplines 
including epidemiology, biostatistics, health economics, sociology, anthropology, 
and policy analysis. Both qualitative and quantitative research methods have 
important roles to play. In some circumstances, interventions can be evaluated 
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using randomized trials—particularly cluster trials where the unit of randomization 
may be communities or health facilities—but such opportunities are often missed.  
Many research questions, however, cannot be addressed by randomized trials—
for example, because they may be system-wide in their scope. Other 
approaches, such as controlled before–after studies and interrupted time-series 
analyses, need to be considered, as well as process evaluations to better 
understand how and why interventions work or do not work as intended. 
Participatory action research has the potential to elucidate both constraints to 
success of interventions and improve the performance of health staff.22  
Recommendations for the improved design and reporting of non-randomized and 
randomized studies (most recently including cluster randomized trials) have been 
published and should be followed.23,24 Contextual factors are generally thought to 
be important effect modifiers but are often poorly described by researchers, 
making it difficult to determine why a particular intervention or policy has been 
effective or ineffective. Better description of relevant contextual factors and more 
attention to assessing the influence of contextual factors on the local applicability 
of research in general and systematic reviews in particular is needed.25  
 
Fostering research networks 
There are specific features of health systems research that argue for promoting 
collaborative networks to develop priorities, improve methodological approaches, 
undertake both primary research and systematic reviews, and strengthen 
research capacity. Firstly, as has already been highlighted, many aspects of 
health policies and systems are heavily influenced by the local context. As a 
result, multicentre and multicountry studies have an important role to play. They 
permit a specific intervention to be studied in contexts that can be both similar 
and different, allowing conclusions to be drawn on the dependence of the 
outcome on the context.   
Secondly, some strategic issues are driven by global or supra-national 
influences, such as the impact of global trade negotiations on the movement of 
health personnel, the spread of private health insurance companies, and access 
to essential drugs. Thus health systems research needs to take into account 
global influences on health systems and to incorporate a global perspective 
about research on issues that may be subject to such influences.  
Thirdly, health systems research capacity is as yet limited in almost all countries. 
It is an interdisciplinary endeavour that demands not only technical expertise, but 
also expertise in relating to and working with policy and other decision makers in 
developing research agendas, conducting and interpreting research, and 
supporting action based on the findings. While training plays an important role in 
developing research capacity, expertise also has to be built “on the job”, by doing 
research.  
The need, on all three counts, for larger and more widely applicable research 
programmes that compare policies and interventions in a range of settings, 
Report of the Task Force on Health Systems Research 10
assess the impact of global factors, and build health systems research capacity 
is thus a strong argument for the development of multicountry collaborative 
health system research networks.  
 
Bridging the gap between researchers and the users of research 
In order to facilitate the uptake of research findings, it is important to bridge the 
gap between the producers and users of research (particularly policy 
makers).25,26 Networks should also provide the opportunity for decision makers to 
interact with each other and with researchers in order to identify common 
problems, issue calls for priority research, and define critical needs from a policy 
development perspective. Such networks will allow for both producers and users 
to be better informed of the needs of the other group and promote joint 
approaches to key issues requiring research.  
The European Observatory on Health Systems and Policies provides one model 
for a support function for public policy makers that could be adapted for low- and 
middle-income countries.27 The secretariat for such an entity could take 
responsibility for identifying topics for systematic reviews, developing actionable 
messages for policy makers from such reviews, and promoting interactions 
between researchers, policy makers, and other stakeholders. 
 
Allocating more funds to health systems research  
Few resources are spent on research directed at health systems issues. Recent 
estimates suggest that only about 0.017% of health expenditure in low- and 
middle-income countries is devoted to such research.28 At a time when 
substantial sums are being made available for the purchase of effective 
interventions and the development of more effective drugs, vaccines, and other 
products, it is essential to channel more resources to address the preparedness 
of health systems to delivering these interventions.  
The ongoing evaluation of the Integrated Management of Childhood Illness 
(IMCI) programme28,29 gives an indication of both the likely scale of resources 
required to evaluate a major international health programme and the potential 
benefits of doing so. The IMCI evaluation, which began in 2000 and will take 
seven years to complete, will cost approximately $10 million.29 The research 
completed to date includes a major cluster trial of the IMCI strategy in 
Bangladesh, which showed substantial improvements in the quality of care for 
children in first-level facilities and a more than three-fold increase in the use of 
such health facilities for the care of sick children.30 It also indicated aspects of 
care where further improvements were needed to capitalize on the full potential 
of IMCI, such as low rates of referral among children with severe illness sent to 
local hospitals. The evaluation will ultimately provide data on the impact of IMCI 
on mortality and on IMCI’s cost effectiveness. A smaller study in Tanzania 
showed improvements in the quality of care and possible improvements in 
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mortality with similar or lower costs in two intervention districts compared with 
two districts that served as controls.31  
The experience with IMCI suggests that a programme of research on a major 
international public health priority topic might cost $10-20 million depending on 
the questions addressed and the scope of the research. Such costs are very 
modest in relation to the overall costs of implementing major programmes and 
have the potential to represent an excellent return on investment. Without such 
research the lessons from failed and successful implementation will not be learnt 
and disseminated. Doubling the current annual health systems research 
expenditure of $134 million28 seems a reasonable aspiration in the near term: it is 
equivalent to a small proportion of the funds committed by the Global Fund to 
Fight AIDS, Tuberculosis and Malaria (around $3 billion) or the U.S. President’s 
Emergency Plan for AIDS Relief ($15 billion requested).  
We note that the Mexico Statement from the Ministerial Summit on Health 
Research, which took place in Mexico City in November 2004, urges developing 
countries to implement the recommendations of the Commission on Health 
Research for Development, which has stated that at least 2% of national health 
expenditures and at least 5% of external donor funds for health should be 
invested in research and capacity building. The Statement also calls for 
governments to allocate adequate funds to support health systems research in 
order to address priority questions.16 If the Mexico Summit recommendations 
were followed for low-income countries, a total of $407 million would be available 
for health research—$278 million from internal funds and $129 million from 
external funds (using 2002 data). For low-middle income countries, the total 
would be $2,082 million—$2,022 million from internal funds and $60 million from 
external funds.31 Therefore, if acted on, the recommendations should be 
sufficient to fund necessary health systems research while still providing 
sufficient funding to support other categories of health research. 
Moreover, ensuring that relevant research is accepted as a legitimate call on 
additional funds of perhaps $50 billion annually—which will become available in 
the event of the launch of the proposed International Finance Facility33—would 
provide a new source of funding for the governments of low-income countries to 
commission such research. 
 
Committing to evaluation  
Making the case for urgent investment in research to evaluate the major 
programmes now being rolled out to deliver interventions for priority diseases 
seems the most promising strategy for scaling up health systems research in the 
near term; such research not only meets the operational needs of programmes 
but also capitalizes on the opportunities to compare different approaches to the 
delivery of effective interventions.34  
It will be important, however, to ensure that the opportunity to investigate cross-
cutting health systems issues relevant to a number of programmes is not lost, 
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otherwise there is a danger that the overall benefits to public health of such 
programmes will be less than anticipated. This could result, for example, from 
competition between programmes for limited health personnel or inefficiencies 
resulting from the introduction of parallel drug delivery and training programmes.  
The recent tsunami that caused such a tragic loss of life in India, Indonesia, Sri 
Lanka, and Thailand has illustrated the importance of strengthening our 
knowledge of how to reconstruct health systems after major disasters. Key 
questions include how best to manage the transition between disaster relief and 
reconstruction and how to improve the resilience of health systems by better 
disaster preparedness.  
Post conflict countries and regions also pose particular challenges and little is 
known about how best to reconstruct health systems and reconstitute health 
workforces in such situations. Post conflict environments may result in a high 
level of physical trauma, for example as a result of landmine and cluster bomb 
injuries. There may be an increased risk of HIV transmission because of the 
presence of large numbers of military personnel and the breakdown of law and 
order, as well as an increased prevalence of common mental disorders as a 
result of exposure to violence. Better evidence is needed about how to integrate 
strategies to address such priorities with those to tackle pre-existing health 
problems in situations where trained health personnel may be lacking and health 
systems are particularly fragmented. 
At the moment, there is no mechanism to ensure that the opportunities for 
research are capitalized on with a view to improving implementation of priority 
interventions and programmes. Research funds are not made available routinely 
alongside global health programmes. And although the Global Fund will support 
research in country to improve the likelihood of implementation, there is no way 
to facilitate the development of appropriate research proposals where research 
capacity is lacking or policy makers are indifferent to the opportunities for 
generating health systems research knowledge and linking that knowledge to 
action.  
Judging by the lack of research that has so far resulted from the Global Fund’s 
investments and the failure of recipient governments to spend monitoring and 
evaluation funding linked to World Bank loans, there is little likelihood that such 
research will arise spontaneously. There is therefore a need to make funds 
available for experienced researchers to work in very close cooperation with  
those developing, managing, and delivering services to ensure that relevant 
research questions are addressed in a methodologically appropriate fashion.  
The sources, management, and mechanisms for the disbursement of such funds 
are matters that will require considerable discussion among stakeholders. 
Nevertheless, WHO can play a key role by ensuring that such research takes 
place and that the findings influence policy and practice. It can, for example, 
make a commitment that all its own priority programmes will be accompanied by 
a rigorous programme of evaluative research (as was undertaken by the IMCI 
programme). In addition, WHO can work with other international agencies, 
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bilateral donors, and major NGOs that fund and implement health programmes to 
develop a code of practice to ensure that evaluation is built in at the beginning of 
such initiatives and that there is a commitment to be guided by the evidence that 
emerges as a consequence.   
 
Conclusions 
Health systems research is essential to reduce our collective uncertainty about 
how to achieve the MDGs and to provide a basis for well-informed decisions and 
actions through which the findings of such research can be implemented. There 
are opportunities to initiate substantial research programmes by collective action 
among research funding bodies and by ensuring that major programmes focused 
on specific diseases or target groups incorporate the evaluation of impacts.  
There are some early indications that the work of the Task Force and others has 
succeeded in drawing attention to the importance of health systems research and 
that the global health research community will respond to our urgent call for 
action. For example, we are glad to note WHO is assessing the feasibility of 
establishing a major new programme on health systems research. Building on 
existing initiatives such as the Alliance for Health Policy and Systems Research, 
its proposed mission will be to promote the generation and use of knowledge in 
strengthening health systems in low- and middle-income countries in order to 
accelerate the achievement of the health-related MDGs, improve equity in health, 
and reduce poverty.  
However, as this report has clearly stated, the primary need is for sufficient 
resources to be made available to undertake major research programmes 
directed at health system barriers to attaining the MDGs. The Task Force 
believes that the best way the proposed WHO programme could catalyse health 
systems research and generate support is through commissioning adequately 
funded projects and programmes that illustrate to policy makers the benefits of 
such research. It should also focus on supporting member countries to take 
coordinated action to strengthen health systems research within countries and, 
especially, across countries. Such a programme could also play a role in 
regularly reviewing the research agenda outlined by the Task Force in the light of 
changing health priorities and challenges.  
Finally, the WHO Advisory Committee on Health Research has an important role 
to play in monitoring progress towards the achievement of the broader  
recommendations that have been made by the Task Force in this report.  
Only a decade exists before the target date for the MDGs in 2015. It is now a 
matter of urgency to ensure that health systems become the focus of national 
and international efforts to improve capacity to deliver effective interventions in 
an equitable fashion to those who can benefit. 
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Appendix 
 
Templates for 12 topic areas 
 
 
 
Page 
Financial and human resources: 
Community financing, social health insurance, and universal coverage 21 
Human resources for health at the district level and below   25 
Human resources for health at the national level  29 
 
Organization and delivery of health services: 
Community involvement 33 
Equitable, effective, and efficient health care 36 
Approaches to the organization of health services 40 
Drug and diagnostic policies  43 
 
Governance, stewardship, and knowledge management: 
Governance and accountability  47 
Health information systems  50 
Priority setting and evidence-informed policy making 54 
Effective approaches to intersectoral engagement in health  58 
 
Global influences: 
Effects of global initiatives and policies (including trade,  
donors, international agencies) on health systems 62 
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Community financing, social health insurance, and universal coverage 
 
What is the problem and why is it important? 
Most low- and middle-income countries provide very imperfect financial risk 
protection for their citizens. As a result, households that lack protection have 
much lower access to care and can be driven into poverty by catastrophic health 
expenses. By contrast, most high-income countries offer universal protection 
against the cost of health care through a variety of schemes that also provide 
means to influence the cost and quality of health care.1 Some middle-income 
countries, such as Thailand, have recently implemented arrangements that 
provide risk protection to the entire populace.2 And in neighbouring Malaysia, all 
citizens have long had access to health-care services in a public system that is 
funded from general tax revenues. But there are still many countries where a 
substantial share of the population has little or no protection. 
A shortage of resources for health services, including severe limits on 
government funding, and the known disadvantages of user fees, have 
encouraged many countries to look for additional sources of funding for their 
health systems. Some have opted for community financing, especially voluntary, 
community-based health insurance, and others for social (compulsory) health 
insurance.3 Community-based health insurance, for example, was recommended 
as a means of additional domestic resource mobilization by the Commission on 
Macroeconomics and Health’s Working Group 2.4 Insurance is not only a 
potential source of additional money for health services, it is also a vital means of 
spreading risk across individuals. Spreading risk protects households with ill 
family members from catastrophic health expenditures. Universal coverage refers 
to a situation where risk-pooling arrangements (funded by tax and/or insurance) 
cover the whole population, and can be achieved either through one 
comprehensive scheme or through a combination of schemes serving different 
population groups. 
 
What is known and what is not known? 
Several reviews of community-based health insurance schemes illustrate how 
they influence financial protection, the utilization of care, health-service quality, 
total funding, and equity, as well as empowerment and institutional 
development.4,5,6,7 Although there are some examples of well-functioning 
schemes, there are many examples of schemes that appear to have made little 
difference in terms of financial protection or access to good quality health care.  
This is due to a number of reasons:  
• In many resource-poor settings, prepayments can make only a limited 
contribution to the direct cost of health care, which means that without 
external support, many schemes struggle to survive or are ineffective.   
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• Schemes are generally small so their contribution towards overall health 
systems goals is very limited. For example, 70% of the schemes covered in a 
review by the International Labour Organisation had 2,000 members or less.5 
• Fairly consistently, the schemes have been found to exclude the poorest 
among the poor—at least in part because they generally charge a flat-rate 
premium that is unaffordable for the poorest.7 
• Direct costs of care are only part of the total cost of health care and only one 
of the barriers to the use of services. 
Still, it is difficult to draw firm general conclusions from the studies because they 
lack common definitions of community-based health insurance and evaluate 
different objectives. Another serious problem is that the studies generally lack 
methodological rigour. For example, of the 127 studies of community-based 
schemes included in the ILO review mentioned above, only one had a high level 
of internal validity.5  
As for social health insurance, the experience in low- and middle-income 
countries is currently not all positive.8 Such schemes often cover only a minority 
of the population (those in formal sector employment), and in some cases attract 
a government subsidy higher than the funding available for health care for poor 
populations. This raises major equity concerns. Although schemes have been 
introduced with the aim of raising coverage over time, this has generally not 
happened in countries with slow rates of economic growth. In Africa, a few 
countries are attempting to establish a nationwide social health insurance 
scheme, taking account of the errors of the past. Obviously, evidence about the 
degree of success or failure of such initiatives would need to be built up. Some of 
the newer schemes in Southeast Asia have experienced substantial problems in 
terms of cost escalation, primarily because the methods used to pay practitioners 
provide incentives to increase service volume without regard to the cost-
effectiveness of the interventions used.1 Not enough is known about how best to 
design social insurance arrangements to achieve equity and efficiency goals.  
Knowledge of universal coverage arrangements comes mainly from high-income 
countries. One of the few sources of information from countries where funding is 
more constrained is a book from a conference.9 But it is of limited value because 
it does not provide in-depth analyses of different experiences and covers very 
few countries outside of Asia. In addition, some of the Asian schemes reported in 
the book have evolved since the material was first published and so some of the 
chapters are out of date.  
 
What research is needed and how will it help? 
Research is needed to examine the potential roles of existing community-based 
health insurance and social health insurance in overall health-care financing 
arrangements and the types of external support that may be needed for their 
successful functioning. In order to evaluate their potential contribution to 
improved health services and health status, research also needs to examine 
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issues such as their role in local institutional development, reduction of out-of-
pocket spending, empowerment of communities, and impact on health-care 
quality. What’s more, their impact on traditional mechanisms of gifting/borrowing 
should be evaluated as there is a risk that schemes might compete with and/or 
replace traditional networks, only to go bankrupt. Finally, research is needed to 
look at how to address the many barriers faced by the poorest households when 
they need medical care (such as lack of knowledge of what services are 
available and how to access them, distance, opportunity costs/indirect costs, and 
direct financial barriers).  
This will require in-depth case studies of existing community-based health 
insurance and social health insurance schemes and their role in national or 
regional financing systems. There is also a role for intervention research to test 
approaches for improving the coverage and impact of those schemes that are 
functioning reasonably well.   
Research is also needed to: 
• assess the financial implications of universal coverage in different 
settings—in particular this would focus on the extent to which people can 
contribute to the costs of universal coverage from their own income and 
the extent to which costs will need to be covered from general tax 
revenues; 
• identify the appropriate benefit package, its costs, and the feasibility of 
implementation; and 
• identify the most efficient and equitable design features of a universal 
scheme, such as revenue raising mechanisms, risk-pooling arrangements, 
provider payment and resource allocation mechanisms, selection of 
providers, governance, management, and regulation. 
This will require both large-scale, comparative, quantitative analyses and in-
depth national case studies. 
As the authors of a recent review of health financing strategies in low-income 
settings conclude: “Larger scale, up-front funding for evaluation of health 
financing initiatives is necessary to ensure an evidence base that corresponds to 
the importance of this issue for reaching development goals.” 10
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Human resources for health at the district level and below   
 
What is the problem and why is it important? 
Human resources for health are central to delivering and managing health 
services. At the district and subdistrict level, health workers are responsible for 
health-service delivery and health systems development in hospitals, clinics, and 
communities. Yet human resources are in crisis in many developing countries, 
particularly across Africa. As the recently published report of the Joint Learning 
Initiative on human resources for health points out, three major forces are 
responsible for the devastating situation: HIV/AIDS; accelerating migration of 
doctors and nurses from countries already suffering chronic labour shortages; 
and the “legacy of chronic under-investment in human resources”.1 The impact of 
internal and external migration is often particularly felt at the district level. This is 
especially true in rural areas where the lack of educational and social 
opportunities for families may act as an added deterrent to the recruitment and 
retention of health professionals. Absenteeism and low productivity are common 
problems in many countries. A recent study from India showed that health 
workers particularly valued training opportunities, good relations with colleagues, 
a desirable location, and good physical working conditions even above better 
pay.2 
The Joint Learning Initiative estimates that there is a shortage of four million 
health workers around the globe. It also notes that sub-Saharan African countries 
will have to add “one million health workers through retention, recruitment, and 
training if they are to come close to approaching the MDGs for health”.1  
In the last 20 years there have been substantial moves towards transforming and 
decentralizing health systems development worldwide. But in most countries, 
particularly in the developing world, human resource development, organization, 
and structure have remained largely unchanged. Furthermore, the evidence base 
for human resource policies is weak because of a lack of robust research.  
 
What is known and what is not known? 
Health systems cannot function without adequate and appropriate human 
resources, yet human resource development does not receive enough attention 
or support within the spectrum of health research and planning. In particular, the 
overall availability and balance of different types of health personnel at the district 
and subdistrict level are often inadequate and inappropriate.  
Various options to address shortfalls in both the number and skill level of health 
personnel are being explored, more specifically against the background of the 
HIV/AIDS crisis. This is the context for the revival of the debate around the role of 
community health workers and the appropriate skills required to provide 
adequate health services at the district level and below. It is known, for example, 
that mid-level and community-based workers have played an important role in 
health-care delivery in countries and in situations when other cadres were not 
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available (for instance, Mozambique and Tanzania). This is of particular 
importance to rural areas in developing countries, which have been the hardest 
hit by the migration of health workers.  
In many cases the evidence of what is known is not systematic enough or is 
fragmented.3 Crucially, in the last twenty years, there has been no documentation 
of experiences and best practices in human resource planning, production, and 
management at the district and subdistrict level. Nor is it known what the reasons 
are for the frequently wide gap between human resource policies and practices.  
A review of the impact of community health workers in Africa illustrated the 
limitations of the evidence, arguing that not enough is known about the impact or 
effectiveness of different models of community health worker programmes.4 A 
recent systematic review of the effectiveness of lay health worker interventions in 
primary care and community health5 found only eight of 44 randomized controlled 
trials meeting the inclusion criteria were based in low- and middle-income 
countries. In 30 studies the intervention was delivered to consumers/patients in 
their homes, while a further ten involved a combination of home, primary care, 
and community interventions. A small portion of the studies used multi-faceted 
interventions that could not be assigned to any one category. There was some 
evidence that such interventions could promote immunization uptake in children 
and adults and possibly lead to the improved diagnosis and treatment of some 
infectious diseases such as malaria. The review concluded that for other health 
issues there is insufficient evidence for the effectiveness of interventions 
provided by lay health workers to make clear recommendations. 
Other categories of community-based health workers may be able to deliver 
interventions and have an impact on health outcomes. In contrast to commonly 
held views, a recent systematic review of research on traditional birth attendants 
identified possible benefits on maternal mortality and perhaps morbidity although 
there were methodological limitations in the research.6 In a landmark study from 
rural India, Bang et al demonstrated that community health workers could 
administer a package of interventions in domiciliary settings that reduced 
neonatal mortality by over 50%.7
While the impacts of migration, particularly of nurses and doctors, have to some 
extent been documented, little is known about how to effectively improve 
recruitment and retention of the health workforce at the district level. 
 
What research is needed and how will it help? 
Research is required on a number of issues relating to the capacity of human 
resources to deliver services at the district and subdistrict level: 
• how to achieve the right balance and strength of clinical and public-health 
competencies at district and subdistrict levels; 
• optimal personnel/skills mix to perform clinical and management functions; 
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• roles, training, and support of mid-level, community-based, and traditional 
health workers; 
• strategies to recruit, retain, and motivate health workers at the district 
level, including the use of financial and non-financial incentives; 
• role of leadership, support, and capacity development in improving and 
maintaining district health systems and service delivery; 
• requirements of those delivering care at the district level (drug supply, 
essential diagnostic testing and information systems, for example); and  
• role(s) of community health workers in overcoming demand-side barriers 
(including those related to gender) that prevent access to and use of 
health services, in achieving the MDGs, and in improving health outcomes 
in general. More specifically, there is a need to evaluate approaches such 
as regular visiting of households, targeting high-risk groups, prescribing 
medications, promoting adherence to treatment, and running community 
health education programmes.  
Clearly, a better understanding of training and capacity development, leadership, 
and management issues at the district and subdistrict level can lay the basis for 
substantial improvements in the quality of care. It should be understood, 
however, that human resource issues by their very nature are cross-cutting. For 
example, they affect and are affected by the planning and management of 
programmes focused on a particular health issue or a specific disease. 
Moreover, what is happening at the national and provincial/state level in terms of 
human resource policy and implementation (see template on human resources at 
the national level) has a direct and profound effect on human resources and 
service delivery at the district and subdistrict level.  
Thus far, methodologies used in research into human resources for health have 
lacked creativity and sharpness. Attention to methodological innovation, with a 
particular focus on participatory approaches that can also enhance service 
delivery, is an urgent requirement if research is to improve in this area. 
In addition, large-scale intervention studies are required, including, where 
feasible, pragmatic randomized trials using accepted approaches to the 
development and evaluation of complex interventions. Finally, there is a need to 
document and synthesize the lessons of managing human resources in 
decentralized health systems that have accrued over the past few decades. 
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Human resources for health at the national level 
 
What is the problem and why is it important? 
The performance of the health workforce is considered by many to be the 
principal constraint to achieving the MDGs and other priority health goals such as 
“3 by 5” (ie, three million HIV-positive people receiving treatment with 
antiretrovirals by the end of 2005). Another template has outlined the general 
problems in human resources for health and identified the priority research 
questions concerning human resources at the district and community level. This 
template considers research priorities and human resources for health needs at 
higher management levels. National level policy and planning decisions are 
required to address the extreme shortages in health personnel facing much of 
the developing world. They are also required to respond to the severe “brain 
drain” due to the migration of qualified health personnel across borders from 
developed to developing countries, as well as within countries from rural to urban 
areas and from the public to the private sector. 
The problems are similar to those identified in the previous template but, in 
addition, ministries of health and provincial health departments frequently lack 
the skilled personnel to enable them to use research evidence to set and 
implement policy priorities or to deal with the demands of multiple, uncoordinated 
donor-driven initiatives. Within the health sector, human resource management 
has for many years been viewed as an administrative function rather than a 
strategic function whose planning and management should be informed by 
research.1  
 
What is known and what is not known? 
Overall, there is a dearth of reliable evidence to inform health workforce policy, 
planning, and management. While research confirms a strong association 
between higher densities of health workers and better health outcomes 
(independently of socioeconomic determinants),2 there is currently little 
understanding of why some countries achieve better outcomes with similar 
densities of health workers. Differences in skill level, occupational mix, urban–
rural and public–private distribution, substitutability, and synergy between 
different categories of health workers need to be taken into account. Also not well 
understood are the influences of complex issues—such as global and national 
macroeconomic trends and health system reform—on the demand for human 
resources for health. 
What little research that has been undertaken in this area has been revealing. 
One example is a study in Latin America that found the two most important 
reform policies—decentralization and privatization—have had a negative impact 
on the conditions of employment and prompted strong opposition from organized 
professionals and unions. In several countries included in the study, the 
workforce became the most important obstacle to successful reform leading the 
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researchers to suggest that it is important to ensure a match between the types 
of personnel needed for reform and the availability of professionals.3  
Another example is a study looking at the migration to the US of physicians 
trained in sub-Saharan Africa. It found that almost one quarter of physicians 
licensed to practise in the US had received their medical training elsewhere, the 
majority (64%) in low-income or lower middle-income countries. In that group 
were 5334 physicians from sub-Saharan Africa—nearly 86% originated from only 
three countries (Nigeria, South Africa and Ghana) and 79% were trained at only 
10 medical schools. The researchers concluded that policy interventions in only a 
few locations could be effective in stemming the brain drain.4
A group of researchers exploring the migration of health professionals concluded 
that “better information is needed to monitor migration flows; source countries 
need to improve staff attraction and retention strategies; and recipient countries 
need to ensure that they do not become a permanent drain on health 
professionals from the developing countries.”5
 
What research is needed and how will it help? 
A prerequisite to the development of effective solutions is a deeper and clearer 
understanding of the issues of supply, demand, and mobility of the health 
workforce. The Joint Learning Initiative has identified four strategies to respond 
to the global human resources for health crisis: “raise the profile of the issue of 
human resources; improve the conceptual base and evidence available to 
decision makers; collect, share, and learn from country experiences; and begin to 
formulate and enact policies at the country level that affect all aspects of the 
crisis.”6  
In the view of the Task Force, particular attention should be devoted to research 
that can build an evidence base and inform national human resources for health 
policy and planning in four areas.   
1. Addressing shortages and imbalances (functional and geographic) by:  
• developing methods to project future health workforce needs and the 
desired skill mix in terms of doctors, nurses, medical assistants, and 
midwives;  
• determining what capacity is needed at higher management levels—
central and provincial/state; 
• coordinating supply and demand to address these needs; 
• developing recruitment, training, and retention strategies—including 
strategies specifically addressing gender-based barriers and 
constraints that prevent women from entering and staying in the health 
workforce;7  
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• identifying effective ways to improve motivation and performance 
(working environment, compensation, non-financial incentives, removal 
of disincentives, supervision, and support); and 
• engaging the private sector effectively (impact of regulation and of dual 
public and private practices on the health system).   
2. Generating a future workforce through education and training with an 
emphasis on building primary health-care skills (see also template on human 
resources at district level) through: 
• creating new cadres of health workers who are not likely to migrate, 
including an adequate number of female workers to improve women’s 
access to primary health-care services;  
• adapting existing training programmes for rapid scale up—teaching 
people what they really need to know to make a difference; 
• developing leadership and managerial capacity, including support and 
education aimed at the higher management level—determine what is 
required to attract and retain highly-skilled managers; and 
• designing and implementing high quality and effective continuing 
professional development programmes and systems of accreditation. 
3. Matching demand and supply to health needs, which will require evaluation of 
the impact of:   
• macroeconomic and public sector reform policies on human resources 
for health (structural adjustment, fiscal stabilization, civil service 
reform, decentralization, health sector financing reform) and how best 
to address any negative consequences of these policies; and 
• donor-driven policies, practices, and initiatives such as Comprehensive 
Development Framework (CDF), Poverty Reduction Strategy Papers 
(PRSP), Medium Term Expenditure Framework (MTEF), Sector-Wide 
Approach (SWAp), etc.  
4. Evaluating the impact of globalization, especially the General Agreement on 
Trade in Services (see also template on global influences), on health labour 
markets and developing effective strategies for reducing adverse 
consequences. The focus should be on:  
• the recruitment of foreign health workers;  
• the migration of highly-skilled workers from poorer to richer regions; 
and 
• the migration of highly-skilled workers from the public sector to the 
private sector. 
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Community involvement 
 
What is the problem and why is it important? 
The importance of community participation in the organization and delivery of 
health services has been emphasized for a long time now as a goal in itself, as 
well as a means of encouraging participatory democracy, public accountability, 
and transparency. The WHO’s declaration of Alma Ata (1978) states that “the 
people have the right and duty to participate individually and collectively in the 
planning and implementation of their health care”.1  
The People’s Charter for Health (2000),2 a significant, consensus document of 
civil society on health-care challenges also emphasized this by noting: “the 
participation of people and people’s organizations is essential to the formulation, 
implementation, and evaluation of all health and social policies and 
programmes”. 
It is widely believed that community participation at all levels of health services 
has a number of desirable effects and that community involvement can achieve 
the following:  
• In planning health-care services, particularly primary health care, it can 
lead to more accessible, equitable, and acceptable health services and 
improve health and quality of life.  
• In developing clinical practice guidelines or health programme guidelines, 
it can help to ensure that these are relevant to the social, economic, 
cultural, and political context of the lives of the people being reached and 
appropriately reflect their values, needs, and aspirations.  
• In health research, it can promote improved quality and relevance, as well 
as a deeper understanding of the interface between health systems and 
the community.  
• In preparing and implementing health promotion and health education 
programmes, it can enhance quality and relevance, and consequently 
improve health outcomes.  
 
Nevertheless, there is a tendency in the literature to equate “community” with 
“consumers” and “patients”, which is possibly the result of an overemphasis on a 
biomedical paradigm and a techno-managerial focus of health services. This may 
lead to “community participation” becoming equated with the concept of “social 
marketing”. Community participation, however, should be seen as broader in 
scope than individual involvement in health-care decisions or promotion of 
specific interventions. It encompasses activities that aim to improve population 
health by addressing the socioeconomic determinants of health, promoting 
“healthy” lifestyles and a healthy environment, and tackling disease specific 
problems.  
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Even though the participation of people in community actions to influence local 
conditions and services has the potential to greatly enhance a health system’s 
capacity to reach the MDGs, it is currently under-researched. A recent example 
of a cluster randomized trial of a participatory intervention with women’s groups 
in Nepal demonstrates that rigorous research is possible in low-income settings 
and that such interventions can have substantial impacts on health outcomes. 
The study found significant reductions in both neonatal and maternal mortality in 
the intervention group compared with the control group.3 
 
What is known and what is not known? 
These beliefs or assumptions concerning community participation are based on a 
large number of primary health-care projects and initiatives at local (micro-level 
civil society initiatives), national, and international levels over the last few 
decades. Few studies, however, have rigorously evaluated the effects of 
alternative ways of achieving community participation in collective decision 
making about health care and the delivery of health services. A Cochrane review 
of interventions to improve consumer involvement in collective decision making 
about health care has not found any evaluations from low-income countries.   
The paucity of studies is partly because of conceptual and operational problems 
related to such research and the difficulties of subjecting community processes to 
evidence-gathering initiatives that need strong grounding in qualitative and 
quantitative methodologies.4 There are at least three broad sets of questions that 
are not adequately understood vis-à-vis community participation.  
The first set encompasses a better understanding of what constitutes community 
participation and how it is to be achieved; what are its relative effects on 
accountability, decision making, health-care outcomes and resource utilization; 
and what are the costs.  
The second set of questions covers how equity differentials within a community—
be they by class, caste, gender, ethnicity, geography, or levels of social 
exclusion—affect community participation, as well as how disadvantaged groups 
and individuals can be empowered to take part in community processes.  
The third set of questions addresses whether community participation processes 
can effectively overcome socioeconomic determinants of ill-health and demand 
side barriers to improving health, including issues such as stigma, gender, public 
trust in health services, governance, and corruption.   
 
What research is needed and how would it help?  
The most important priority is systematic reviews of studies that examine the 
effectiveness of different ways to promote community involvement. Also required 
are descriptive or qualitative studies that document different approaches to 
achieving community involvement in countries with different levels of economic 
development, health system capacities, and political systems. This would help 
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our understanding of the complexities and challenges of enhancing community 
involvement.    
Another area of research would be to document and assess barriers to 
community involvement, particularly the social factors that affect people’s access 
to health care and to community processes. There is a need to develop and 
evaluate creative approaches and initiatives that have tried to circumvent the 
barriers.  
Studies looking at the impact of community involvement on demand for and 
access to effective interventions to address the MDGs will also have to be 
undertaken.  
All these studies must avoid reducing communities to passive beneficiaries or 
consumers of health services; true community involvement implies active 
participation in decision making that starts at the planning stage and continues 
on to organizing, managing, monitoring, and evaluation.  
The use of participatory research methodologies should be encouraged to help 
poor communities shape health systems to meet their own needs. 5,6
 
References 
1. WHO. Primary health care: report of the International Conference on Primary 
Health Care, Alma-Ata, USSR, September 6-12, 1978. Geneva: World Health 
Organization, 1978.  
2. People’s Charter for Health. Savar: People’s Health Assembly, 2000. 
(www.phmovement.org) 
3. Manandhar DS, Osrin D, Shrestha BP, Mesko N, Morrsion J, et al. Effect of a 
participatory intervention with women’s groups on birth outcomes in Nepal: 
cluster-randomized controlled trial. Lancet 2004; 364: 970–79. 
4. McCoy D, Sanders D, Baum F, Narayan T, Legge D. Pushing the 
international health research agenda towards equity and effectiveness. 
Lancet 2004; 364: 1630–31. 
5. Winter R, Munn-Giddings C. Action research as an approach to enquiry and 
development. In: A handbook for action research in health and social care. 
London: Routledge, 2001; 9–26. 
6. Martin K, de Koning K (eds). Participatory research in health: issues and 
experiences. London: Zed Books, 1996; 1–18. 
 
Report of the Task Force on Health Systems Research 35
Equitable, effective, and efficient health care 
 
What is the problem and why is it important? 
Much of the burden of disease in low-income countries is preventable with 
existing, low-cost health interventions.1 While partly due to persisting poverty, 
unacceptably high rates of morbidity and mortality in the developing world can 
also be attributed to the inadequacy of health systems.2 In most countries, 
achieving the health-related MDGs will require a dramatic expansion in the 
delivery and effective coverage of essential health interventions.3 This in turn will 
require strategic investments to strengthen health systems in a sustainable and 
equitable way.  
Inefficiencies in the allocation of resources for health and in the delivery of health 
services lead to poor quality health care, which is a deterrent to health service 
use and a cause of poor outcomes for those who have no alternative but to use 
inadequate services. Such inefficiencies must be addressed systemically (see 
template on priority setting). If they are not, they could be magnified by global 
health initiatives, which tend to concentrate largely on supplies and commodities 
and invest little in the development of sustainable and equitable delivery systems 
at the local level.  
Global health initiatives also tend to ignore the diversity of national health 
systems in resource-poor settings. In addition to all categories of providers and 
facilities, health systems can include communities, households, families, and 
individuals who can affect whether and how health care is accessed and used. 
Health services need innovative approaches and dedicated resources for primary 
health care to reach beyond the health-service delivery provided by hospitals and 
health centres. 
Inequitable social conditions powerfully influence health status and access to 
health care.4 It is often easier to reach the least poor. As a result, improving the 
effectiveness and efficiency of health systems to deliver essential health 
interventions eventually creates tensions in terms of equity. Societies must be 
ready to pay an “equity-premium” to ensure that the poorest have equal access 
and benefit, even though the cost-effectiveness of approaches to reaching them 
may be lower than for other groups. As it is often the case that women are 
disproportionately represented in the lowest economic quintile of a population, 
special attention must be paid to improving their access to quality health-care 
services. 
 
What is known and what is not known? 
The obstacles to increasing coverage of effective health care are fairly well 
known and exist at all levels.5 But there is little evidence about which bottlenecks 
are the most problematic, how these constraints can be overcome, or how 
contextual factors influence the most appropriate mix or integration of strategies. 
For example, it is not known which approaches might work best in the most 
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highly resource-constrained settings; what might be the appropriate roles of the 
private-for-profit, not-for-profit, and NGO sectors; what are the merits of different 
approaches including direct public service delivery, contracting, and franchising 
(eg, a national NGO gives the right to provide services on its behalf to a local 
organization that has agreed to adhere to certain standards). There is even less 
evidence about how to ensure the poor are preferentially reached. 
There is growing awareness of the impact of inequitable access to effective 
health care on health and wealth. For example, it has been established that poor 
quality primary health-care services can push the poor further into poverty.6 But 
there is little evidence about the impact and relative cost-effectiveness of 
attempts to improve access for disadvantaged populations and quality of care in 
resource-poor health systems. Tools that work at the central level do not 
necessarily work at the district and local levels (see template on approaches to 
the organization of health services). Little is known about the performance of 
interventions to improve the uptake of effective interventions that have been 
evaluated in high-income countries, including audit and feedback, supportive 
supervision, and educational outreach.7   
There have been many studies about health-seeking behaviour for formal and 
traditional health services, but there is little information on the beliefs about 
home-treatment practices. A number of studies have documented the high cost 
in time and money of caring for sick people, but there is little systematic evidence 
of how different kinds of support services (hospitals, nursing homes, community 
support) affect the burden on and poverty of households. 
 
What research is needed and how would it help? 
Research is needed to evaluate the impact of global health initiatives on national 
health systems and determine how these initiatives can integrate, strengthen, 
and take advantage of local synergies to develop sustainable delivery systems at 
the local level.  
Regional or national health policy observatories that foster joint working between 
researchers and policy makers have the potential to develop and maintain up-to-
date profiles of the key features of national health systems as they relate to 
equitable, efficient, and effective health care.8,9 Observatories could identify or 
conduct systematic reviews of the effects of alternative strategies on access to 
and quality of health services. They could help identify the most important 
deficiencies in quality of care in specific settings, together with investigating the 
barriers to narrowing those gaps and the development of strategies to improve 
the uptake of effective interventions. Their contribution requires evaluation in low-
income country settings. 
For greater efficiency in health-service delivery, more research and innovation is 
needed in developing integrated approaches to health care, especially when a 
number of services are bundled at the point of contact as they are with 
interventions such as Integrated Management of Childhood Illness initiative. This 
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should be accompanied by rigorous evaluations of the effectiveness and costs of 
promising interventions and processes. Such evaluations will lead to a better 
understanding of when and why interventions are or are not effective and to the 
development of feasible methods for monitoring quality of care in low-income 
countries.  
More research is needed on how to address the health-care needs of the poorest 
within low- and middle-income countries, especially the needs of those living in 
urban slums or remote rural areas.  
A better understanding of local drug markets, knowledge and practices in home 
care, and the functioning of private sector is also needed (see also the template 
on drug and diagnostic policies). This includes understanding how the drugs 
supplied through global health initiatives are used in home care and evaluating 
approaches to regulating the private pharmacy sector.10  
The growing volume of literature on interventions to improve case management 
by the mother/caretaker and the private provider, be it a clinic or a village drug 
shop, needs strengthening by further multi-site research to evaluate the impact in 
different settings. Also needed are intervention studies of home-care education 
programmes focusing on specific health problems (such as the treatment of 
childhood fevers), the prevention and treatment of diarrhoea, family support for 
patients receiving antiretrovirals, and alternative approaches to support 
households with a family member suffering from a chronic disease.  
More research is needed in low-income settings of approaches to improving the 
quality of care that have been evaluated in developed-country settings. 
Narrowing the quality gap may require a combination of interventions. 
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Approaches to the organization of health services 
 
What is the problem and why is it important? 
For the last 15 years, reforming the organization of health services has been 
viewed as a key solution to the inefficient and inequitable delivery of health care 
in developing countries. Such reforms, influenced by the approach often known 
as New Public Management, include separating the functions of purchasers and 
providers; creating internal or quasi markets within the public sector; creating 
executive agencies to manage the health sector; decentralizing health-service 
management to local health administrations or to local government; increasing 
the autonomy of hospitals; and making greater use of the private sector.1 But 
such reforms have had mixed results, especially when they were not adapted to 
local circumstances.2 As there have been relatively few success stories, the 
value of these reforms has come into question. The problem is there are few 
universally agreed ways forward.  
One of the most controversial areas in the organization of health services, 
particularly in low-income countries, has been whether health improvements are 
best achieved by disease or programme specific “vertical” approaches or through 
“horizontal”, comprehensive care approaches.3 In practice, few diseases or 
patient groups are dealt with solely through dedicated programmes that are 
unconnected to the wider health system. In many cases care is organized 
through a complex mixture of services. In some cases programmes may be 
managed through a vertical, disease specific approach but delivered in an 
integrated fashion. A greater emphasis on vertical programmes is sometimes 
promoted when health systems are weak. This may be because of well-founded 
fears about their capacity to deliver, and the short-term time horizons of funders 
who are unwilling to spend the time needed to seek gains through more 
comprehensive approaches or work within existing systems. It is unclear, 
however, when a vertical approach or a horizontal approach is more appropriate. 
It is also unclear when the emphasis might be shifted from a vertical to a 
comprehensive approach or how best to integrate such programmes into health 
systems.  
 
What is known and what is not known? 
A fair amount is known about the advantages and disadvantages of different 
reforms in various settings such as giving increased autonomy to hospitals4 and 
private sector participation.5 But the literature is scattered and partial in its 
coverage of issues. Moreover, reviews have generally been undertaken with an 
eye to making policy points, often from an ideological standpoint, with little 
attention to the methodological rigour of the evidence.  
There is growing awareness of the need to ensure that disease-specific initiatives 
support rather than erode health systems. But there is little knowledge about how 
this can be done effectively, particularly when resources typically are available 
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for specific interventions or programmes and not for supporting health systems 
directly. For example, little is known about the potential competition between 
different programmes for limited numbers of trained staff when two or more 
interventions are scaled up simultaneously and how services are best organized 
to optimize their use. 
A recent review has drawn attention to the importance of conceptually separating 
the vertical and horizontal administrative organization of a programme from 
whether it is selective or comprehensive in its coverage of diseases of 
conditions.6 For example, the Integrated Management of Childhood Illnesses 
initiative (IMCI) takes a horizontal, comprehensive approach to providing health-
care services for children. But the review noted the programme was only 
successful when it was accompanied by strong vertical management at the 
national and district level.   
 
What research is needed and how will it help? 
Many different types of research are needed including in-depth case studies and 
large-scale quantitative studies.   
Topics include: 
• strengths and weaknesses of different organizational designs for the 
purchasing and provision of services; 
• the most appropriate mix of vertical and horizontal organizational 
structures for different diseases and conditions in different situations—with 
attention to differentiating between programme management and delivery 
strategies; 
• equity and efficiency implications of contracting health services to NGOs 
on a large scale; 
• equity and efficiency implications of provider competition between various 
vertical programmes; 
• relationship between patterns of decentralization and health outcomes; 
• strengths and weaknesses of different ways of involving the private sector 
in health provision; 
• impact of vertical programmes on the health system; 
• best ways of “going to scale” in different health programmes; and 
• approaches to strengthening the focus of health systems on health 
outcomes. 
Initial conceptual and methodological research is also required to categorize the 
key features of health systems so that an analysis of different experiences can 
take into account the local context that affects reform experiences.7 If the 
evidence base on organizational patterns and reforms is strengthened, it will be 
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possible to give advice to policy makers that is based on firmer empirical 
evidence. 
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Drug and diagnostic policies 
 
What is the problem and why is it important?  
Low-income countries face many challenges in providing access to essential 
drugs. Among the greatest challenges are counterfeit drugs, problems with the 
supply, distribution and financing of essential medicines, leakages from the 
public sector to the private sector, and the weak regulation of prescribing.1,2 
Pharmaceuticals make an important contribution to people's health but they are 
frequently used inappropriately. The inappropriate use of drugs contributes to the 
poverty trap and to the rise in bacterial resistance to inexpensive generic 
antibiotics.3 Improving the use of drugs can improve health outcomes as well as 
result in large savings without adverse health consequences. To have an impact, 
efforts to improve the use of drugs must include private drug outlets, which often 
function as de facto health centres.4 This is where the majority of drug 
distribution takes place in many low-income countries.  
People in low-income countries often pay for drugs out of their own pocket and 
costs may amount to 60-90% of their total household expenditure on health.5 
Ability to pay is also a concern for governments—increasing expenditures on 
drugs puts pressure on policy makers to control drug costs and ensure that funds 
are well spent. Cost-containment strategies also can have unintended adverse 
effects on health and paradoxical effects on costs, for example, by increasing the 
burden on the health system of diseases that could potentially be treated. 
An incorrect diagnosis is one reason why drugs are often used inappropriately. 
Appropriate diagnostic facilities for the diagnosis and management of health 
problems are critical. Such facilities range from simple tests to diagnose 
infectious diseases to those used for the screening and management of non-
communicable diseases and for managing emergencies.  
The potential costs associated with diagnostics in public and private health 
systems in developing countries is substantial, approaching 10-15% of all health-
care costs in some countries.6 However, the evidence base supporting the 
utilization and assessment of diagnostics is poor. Although the criteria for 
developing, introducing, and using diagnostic tools and products should be the 
same as that applied to pharmaceuticals and other interventions and products, 
this is seldom the case.  
The importance of bio-diagnostics in developing countries and the role of a 
potential “essential diagnostics” programme have been recognized but have yet 
to be rigorously evaluated.7  
  
What is known and what is not known? 
There is little reliable evidence about the effects of the most commonly used 
pharmaceutical policies—formularies, administrative restrictions, price controls, 
advertising and marketing restrictions, and the regulation of drug benefit 
Report of the Task Force on Health Systems Research 43
programmes have rarely been rigorously evaluated. Preliminary results of a 
Cochrane review of the effects of pharmaceutical policies indicate that there may 
be as many as 100 evaluations across a broad range of policies. Although they 
are relevant to low-income countries,8 most of the evaluations have focused on 
costs and have not evaluated the health effects of drug policies. 
While evidence, standards, and criteria for appropriate diagnostics exist for 
referral hospitals, few studies have evaluated the potential of these interventions 
in other health system settings, and there have been even fewer systematic 
reviews addressing these problems. A detailed search of the Cochrane library 
indicates that few diagnostic technologies and tools have been evaluated at 
scale using basic criteria such as clinical outcomes and cost-effectiveness.8 An 
example is the Widal serological test, the most widely used diagnostic test for 
typhoid fever, one of the most common bacterial infections in low-income 
countries. The test, which is over a century old, has never been evaluated at 
scale in a health system setting. In contrast, several new and expensive 
diagnostic tests have been developed and are being introduced into health 
systems without an adequate evaluation on a scale comparable to other 
interventions such as therapeutic regimens or vaccines.9  
 
What research is needed and how would it help? 
Systematic reviews of the effects of pharmaceutical policies on appropriate drug 
use are needed for policy makers to make informed decisions about drug 
policies. Rigorous evaluations of the effects of drug policies, including health 
effects and the effects on the utilization of other health services are needed. 
Drug policies can include both incentives and disincentives for patients, 
physicians, pharmacists, distributors, and manufacturers. There is a need for 
process evaluations and modelling to improve the understanding of these 
different incentives, and when and why drug policies have both intended and 
unintended effects. There is also a need to develop, evaluate, and implement 
feasible methods for collecting and analysing prescribing data in low-income 
countries. 
Some specific priority research questions include: 
• As part of the ‘3 by 5 programme’ many countries are attempting to 
streamline the distribution of antiretrovirals for the treatment of HIV/AIDS. 
To what extent can other essential medicines be included in this process? 
• How can the distribution and sale of pharmaceuticals in the private sector 
best be regulated and what measures need to be taken to prevent 
leakages from the public sector?  
• What is the impact of drug company marketing activities on the demand 
for pharmaceuticals? 
• How can counterfeit drugs be reliably detected and their distribution 
prevented? 
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Research is needed to assess the potential value of diagnostics in developing 
countries. This can be done by addressing three key issues: 
• the evidence base supporting the efficacy of the diagnostic procedure or 
test in terms of decision making and eventual health outcomes at an 
individual level; 
• the impact of the introduction of the diagnostic test or procedure at scale 
on outcomes at the health system level; and  
• the cost-effectiveness of the diagnostic test in relation to different types of 
settings and uses.  
With the advent of genomics and molecular diagnostics there is enormous 
pressure to introduce these diagnostic modalities at all levels of care in some 
developing countries, frequently on the basis of data from referral hospital 
settings. Developing countries themselves are investing in these technologies but 
with limited plans for their systematic evaluation. Moreover, few studies have 
evaluated the potential role of the systematic introduction of laboratory and 
surveillance systems in health system settings.  
Several other approaches can be taken to evaluating diagnostics. One option is a 
“beneficence index”, which is derived by rating seven different factors (need, 
efficacy, additional quality adjusted life years gained, ease of integration, etc).10 
The goal is to evaluate diagnostics as rigorously as other health interventions 
and eventually use well-designed research protocols at a scale that is 
commensurate with their utility in health system settings. The findings of such 
research would lead to improved quality of care with consequent improvements 
in the uptake of cost-effective treatments. 
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Governance and accountability 
 
What is the problem and why is it important? 
Good governance appears to be key to the effectiveness of general development 
assistance.1 This has been borne out by a recent study focusing on the health-
related MDGs.2 Research has suggested that weak governance and poor 
accountability are surprisingly widespread in the health sector.   
Ensuring strong systems of governance and appropriate accountability 
mechanisms within the health sector underpins all aspects of health-system 
performance. Where governance and accountability structures fail, multiple 
problems within the health system will emerge. For example, health providers 
who are not held accountable for their performance are likely to be unresponsive 
to community and patient preferences; this may in turn reduce the demand for 
care. A lack of accountability within procurement systems may waste money, 
lead to a depletion of essential drug stocks (see also the template on drug and 
diagnostic policies), and to the leakage of potentially dangerous pharmaceuticals 
into the black market. Where governance and accountability structures are very 
weak, corruption may become pervasive. Corruption wastes money, distorts 
incentives, and is likely to reduce efficiency within the sector. For example, if 
contracts for services are awarded on the basis of personal contacts and bribes, 
then this is likely to adversely affect the quality of services provided by the 
contractor. 
It is often this perception of failed or insufficient accountability that furnishes the 
impetus for health-sector reform. Strengthened accountability and improved 
governance are important objectives of programmes of decentralization, 
establishment of hospital boards, community-based health insurance schemes, 
and consumer rights bills. Such reforms, however, are frequently based upon a 
remarkably limited understanding of how governance and accountability 
structures actually operate in the health sector and how they may best be 
improved. 
 
What is known and what is not known? 
The state of knowledge about governance and accountability within the health 
sector is only weakly developed. A World Bank study, conducted in more than 50 
developing and transitional countries, found that in many nations poor people 
had little trust in the governance mechanisms within the health sector. In 
addition, they believed that their voices counted for little yet they faced 
widespread demands for informal payments when seeking care.3 Several studies 
focusing on the impact and effectiveness of decentralization have highlighted the 
importance of clear and well-understood accountability structures.4 There has 
also been some interest in hospital governance, particularly relating to 
autonomous hospitals. Despite the development of a conceptual framework for 
mapping accountability structures,5 there has been no comprehensive attempt to 
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understand the way in which different health-sector entities are governed or held 
accountable, or which types of strategies may best be employed to improve 
accountability. 
There have been a few studies on corruption in the health sector, notably a 
series of studies of different aspects of corruption in Latin American hospitals.6 In 
India, multiple studies have documented the problem of high-level corruption in 
regulatory agencies and what this means for effective regulation. In general, 
however, high-level corruption is much harder to investigate than lower level 
forms, such as informal payments. There is also a growing body of knowledge 
about the magnitude and practice of informal payments, why they occur, and 
their implications for the accessibility, affordability, and efficiency of care.7  
The Benchmarks of Fairness, proposed by Daniels et al, include “democratic 
accountability and empowerment” for evaluating health-sector reform proposals.8 
These benchmarks provide a framework for integrating equity, efficiency, and 
accountability—and thereby social justice or fairness—into health services. Such 
accountability includes transparency in global budgeting, fair appeals processes, 
adequate privacy protection, and measures to enforce compliance with rules and 
laws. 
 
What research is needed and how would it help? 
Given the limited body of knowledge in this area, preliminary research and more 
applied, policy-oriented studies are needed. Exploratory studies are required on 
the nature and use of explicit, public procedures for evaluating health services; 
the prevalence of transparent allocation decisions; the availability of appeals 
procedures; and documenting effective means of strengthening civil society in 
different contexts.   
In terms of more applied studies, significant understanding of the nature of 
informal payments already exists, but more operational research is needed to 
investigate alternative strategies to eliminate such payments or at least mitigate 
their worst effects. Multiple aspects of corruption could be investigated, but in 
view of growing development assistance expenditures on drugs, particularly 
antiretrovirals, it is imperative to study the nature and quantity of leakages of 
prescription pharmaceuticals from the public sector, and the interests that allow 
this to continue.  
A focused effort is needed to investigate governance structures for a variety of 
key health-sector actors (primary care and hospital providers, insurers, 
regulators, pharmaceutical industry) and different types of accountability 
(financial, performance, democratic).  
More specifically, priority research questions include: 
• What governance structures and mechanisms are most effective for 
models of decentralization? 
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• What are the most effective governance and accountability mechanisms 
for public-private partnerships? 
• What is the impact of effective governance and accountability measures 
on the under use, over use, and misuse of health-care services in both 
public and private sectors? 
• How does industry’s sponsorship of research, its continuing medical 
education activities, and its marketing and advertising programmes 
influence use of health services. 
• How can governance and accountability mechanisms be strengthened to 
reduce corruption, improve patient safety and quality of care, and ensure 
the quality and safety of drugs, vaccines, and other interventions? 
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Health information systems 
 
What is the problem and why is it important? 
The development of health information systems (HIS) worldwide is poorly 
coordinated both within and between countries and is relatively disconnected 
from health research systems. Large infrastructure investments, mostly driven by 
bureaucratic and administrative purposes, have failed to produce the expected 
results even in wealthy countries.  
“One in seven hospital admissions in the US could be avoided if doctors had 
enough information on previous episodes”, said Tommy Thompson, the US 
Secretary of the Department of Health and Human Services, at an OECD 
meeting in Paris in 2004.  
Although the correct functioning of a modern economy is only possible with the 
use of powerful databases and information systems, very little exists in the health 
sector that can drive systems towards a systematic application of evidence-
informed principles. 
Almost everywhere information systems are data heavy but information light. 
Typically they are riddled with inaccurate data, expensive to operate, time 
consuming for large numbers of health staff, and fail to produce information that 
could be used to prioritize health needs and improve health-service delivery.1,2
The great potential of HIS to support social welfare and public health is becoming 
a missed opportunity. This is particularly true in developing countries where 
international programmes focused on specific health priorities have influenced 
the implementation of fragmented HIS with different schemes producing 
information that is frequently scattered and patchy.3,4    
HIS in resource-poor countries are usually imposed in a top-down authoritarian 
manner, which results in managers and staff, especially at the district and facility 
level, feeling powerless. Data are often collected, but information is rarely 
returned in a usable form to those most needing it. Consequently, citizens suffer 
from poor feedback from their health-care practitioners and the system is neither 
transparent nor consistent. Routine health information is collected by a very large 
number of health workers who have received only rudimentary instruction on the 
practice and goals of HIS. As a result, there are many errors and resources are 
wasted because the data are scarcely usable.  
Another problem is related to data exchange and privacy protection. While 
regulations to promote confidentiality in the use of personal information are 
sensible and should be fostered, the conduct of large-scale epidemiological 
research—which could contribute substantially to solutions to global problems—
is being hampered by growing bureaucratic obstacles.  
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What is known and what is not known? 
It is well known that HIS have the potential to improve health outcomes by 
measuring health needs, assisting in prioritizing appropriate health services, 
indicating what input resources are required, monitoring the provision of services, 
measuring the level of health-service outputs, and assessing what effect these 
health services have had on health outcomes.1,5 Importantly, HIS could also be 
used to assess effectiveness, efficiency, quality of care, and equity. The basic 
structure of a comprehensive HIS, as well as the measuring methodologies and 
the information technology requirements, have all been well established.1,2  
Little research has been done in developing countries on how to implement HIS 
in ways that are developmental, empowering, low cost, and of high benefit.2,6 It is 
also unclear how to link new HIS to those already existing in developed countries 
in ways that ensure the technology will be consistent, standardized, and applied 
using a common methodology. A two-tier approach—where a “rich” model 
dominates industry solutions at the same time as more practical models are 
developed for health systems—should be avoided. How to align such different 
philosophies through the identification of a common solution is an important 
research topic that is poorly supported and generally neglected. 
 
What research is needed and how would it help? 
The research required should involve potential users at all levels to ensure the 
development and implementation of sustainable low-cost national health 
information systems that are realistic and appropriate to the needs of resource-
poor countries. Specific priority research areas are briefly outlined in the following 
paragraphs.  
The identification, construction, and maintenance of district-level health indicators 
(DHI) based on standardized minimum datasets is required.2,6 Although sharing a 
common structure, DHI should be customized to local needs and include 
solutions that monitor and evaluate health priorities such as HIV/AIDS, malaria, 
tuberculosis, and child health. DHI should also support improvements in health 
services organization, pharmaceutical supply, human resources development, 
and health system financing. Ensuring local relevance as well as global 
comparability is key to making sure that HIS support the achievement of the 
MDGs. 
The cost-effectiveness of HIS needs to be enhanced and improved. To reach this 
goal, it is essential that novel procedures are carefully identified and tested in the 
field through the launch and evaluation of a comprehensive data accuracy 
enhancement programme. More research is needed to solve problems related to 
the operations of HIS. An essential aspect of such research is to identify formal 
methods that can be used to investigate to what extent an existing HIS may be 
judged effective for population health, and if it is not effective, how to improve it. 
One question for research to answer is how to assist managers at all levels of the 
health system to incorporate routine information, as well as evidence from 
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research, into their planning and decision making3,4 (see also template on priority 
setting and evidence informed decision making). This topic includes developing 
and evaluating systems to provide an effective synthesis between the scientific 
evidence base and routine data collection. This would, for example, include 
strengthening the capacity for capturing and using epidemiological data in health 
systems by supporting disease surveillance and routinely conducted health 
surveys.7  
Another research question is how to use community information systems to 
facilitate accountability of health-service providers, promote equity, and 
encourage community participation in decisions around prioritizing and 
responding to health needs in a locally acceptable manner (see also templates 
on community participation and priority setting). Such systems would extend the 
operations of HIS beyond the strict boundaries of health information.  
Customized software databases and statistical applications to manage the data 
within the HIS require development and evaluation.Ideally, these software 
applications should be open-source, end-user friendly, and flexible.8,9 Open-
source software would entail minimal cost to health departments.  
In addition, novel approaches are needed to ensure that both privacy and 
scientific advancement are safeguarded. Developing countries have enormous 
intellectual potential and can benefit from cooperative action in this regard.  
Members of the Task Force also see the need to develop resources that could be 
used to advance health systems and epidemiological research. For example, 
databases containing large amounts of de-identified data, enriched by population 
and contextual information (demographic, service organization, health indicators, 
etc) could facilitate both data mining and hypothesis-driven research. There is 
also a need to ensure that database and statistical applications are structurally 
linked to an ever-expanding “international concept and data dictionary” that will 
include all relevant details on international standards that form the foundations of 
HIS.10  
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Priority setting and evidence-informed policy making 
 
What is the problem and why is it important? 
Expenditures on health in many countries are being disproportionately spent on 
health services that have a low overall health impact and that disproportionately 
benefit the rich. This situation is likely to remain unchanged without an explicit 
consideration of priority setting and more generally of evidence-informed policy 
making. Resource allocation is too often dictated by historical patterns and a 
desire to benefit or at least avoid challenging vested interests. Today there is 
increasing emphasis on the role of SWAps (sector wide approaches) and PRSPs 
(poverty reduction strategy papers) in building consensus around health sector 
priorities. When developing strategies to achieve these priorities, evidence-
informed policy making is of particular importance. It can help redress current 
imbalances in resource use and help ensure that a country's limited resources 
are targeted at the greatest need.  
As with any health policy issue, however, setting priorities and developing 
strategies to achieve these priorities is about influential individuals and groups, 
the decision-making processes they are seeking to influence, and their exercise 
of political power. Evidence is only one ingredient in the mix but a potentially 
potent one because it can be used to achieve consensus on how to solve 
particular problems at hand or to bring about a different collective appreciation of 
a problem or an approach to addressing a problem.1  
 
What is known and what is not known? 
Much is known about the efficiency of different health interventions.  A popular 
approach to measuring efficiency is through cost-effectiveness analyses. The 
WHO-CHOICE project provides these data at the regional level for an increasing 
range of illnesses and associated interventions. The Disease Control Priorities 
Project and the Commission on Macroeconomics and Health (and previously, the 
World Development Report 1993) use cost-effectiveness data to help define 
priority benefit packages for developing countries. However, evidence on the 
costs and effects of approaches for going to scale are extremely limited, since 
much of the information on cost-effectiveness stems from one-off research 
studies and small-scale implementation efforts.2  
More needs to be known about how best to measure equity in health system 
settings and how to combine equity and efficiency concerns in priority setting 
(see also template on equitable, effective and efficient care). As well, such 
technical approaches to priority setting need to be creatively combined with other 
approaches (see template on community involvement). 
Little is known globally about how best to ensure the implementation of priorities, 
including through decentralized health systems, or how to encourage the take-up 
of research findings and research-based interventions in health systems. 
Perceptions of an innovation, the characteristics of individuals adopting it, and 
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numerous contextual factors are said to influence the rate of diffusion of an 
innovation.3 Effective knowledge translation mechanisms targeted at those who 
can take action are essential.4 However, according to a recent review, the 
literature on the factors that influence policy makers’ use of evidence is still quite 
weak and evaluations of interventions targeted at policy makers are lacking.5 
Without this knowledge, priority setting exercises will remain on paper and policy 
making more generally will remain uninformed by research. 
Using burden of disease/cost-effectiveness as an instrument for district health 
planning and resource allocation did not function well in Uganda.6 However, 
experience in Tanzania suggests that with appropriate tools that indicate how 
current patterns of resource allocation relate to the burden of disease, district 
managers can shift resources into interventions that maximize the health benefit 
for the available resources.7 In Lao People’s Democratic Republic, decision 
makers were included in the formulation and implementation of health systems 
research projects in order to encourage links between research and action.8  
Recent studies and reviews of the relationship between health systems research 
and policy,9 including how to spread and sustain innovations in health-service 
organization and delivery,10 are helping to provide guidance and define a 
research agenda that can shed light on implementation questions.  
 
What research is needed and how will it help? 
Evaluation of a country's existing (implicit) health sector priorities by investigating 
the structure and flow of health expenditures is required. The National Health 
Accounts framework and methodology, at an aggregate and subsector level 
(HIV, malaria, tuberculosis, EPI, etc), could be utilized. This can show the 
inefficiencies and inequities of current resource allocations within the health 
sector. It can also help to assess the appropriateness of current vertical 
programme initiatives. 
At a country level, an analysis of the impact of redistributing resources to health 
interventions that are shown to be more cost-effective is needed. This can show 
the potential for improving a country's overall health situation from existing 
resources. In particular, it can be used to show the best combinations of 
interventions to reach the health-related MDGs efficiently. 
Different approaches to implementing priorities, including those that are based at 
the district level in decentralized health systems, need to be experimented with 
and evaluated. This can show both the approaches that work best, and the 
implementation processes that are likely to have an important influence on the 
success of implementation (for example, the extent to which important 
stakeholders are brought on board). Studies of barriers and incentives for change 
are needed. 
Attention must be given to the development and testing of a conceptual 
framework and the design of a process to explicitly and transparently incorporate 
important equity concerns into priority setting—including the potential for 
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catastrophic expenditures, non-health impact of health interventions, and other 
ethical issues. The process can be tested in several countries using a 
standardized case study approach. This can highlight existing inequities, while at 
the same time show what tradeoffs exist between efficiency and equity and other 
societal concerns. 
Another area of study is the processes through which particular innovations in 
priority setting for health-service delivery and organization are implemented and 
sustained (or not) in particular contexts and settings, and how these processes 
can be enhanced.  
Research can also shed light on the factors that influence the use of research in 
policy making and what interventions can be used to modify these factors. With 
such knowledge, researchers could be better supported in their efforts to develop 
messages for policy makers and fine-tune their approach to knowledge 
translation to these policy makers, policy makers could be better supported in 
their efforts to acquire, assess, adapt and apply research, and both researchers 
and policy makers could be better supported in their efforts to build partnerships 
that enhance the policy relevance of research and the extent to which research 
informs policy and practice. 
The design, implementation and evaluation of units to support policy makers in 
their efforts to use research is another priority area. The European Observatory 
on Health Systems and Policies (www.euro.who.int/observatory) provides a 
model for a support function for public policy makers that could be adapted for 
low- and middle-income countries. The secretariat for such an entity could take 
responsibility for identifying topics for systematic reviews, developing actionable 
messages for policy makers from such reviews, and promoting interactions 
between researchers, policy makers, and other stakeholders. 
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Effective approaches to intersectoral engagement in health 
 
What is the problem and why is it important? 
Political, cultural, social, and economic determinants of health exert powerful 
influences on health worldwide. The recent constitution of the WHO Commission 
on Social Determinants of Health bears testimony to the importance of other 
influences beyond the health sector on health outcomes.1 This template is not 
intended to develop a comprehensive research agenda in this vast field. Instead, 
it will focus on how the health system can more effectively engage other sectors 
to become involved in the advancement of health.   
This is important because of the many ways in which other sectors affect 
health—both by influencing the determinants of health and by their impact on 
health systems. The most obvious example is access to clean water and 
sanitation, which is important for improved health and the reduction of deaths 
from diarrhoea. But there are many other examples. Agricultural policies related 
to ensuring access to essential foods and adequate vector control can 
significantly reduce the incidence of micronutrient deficiencies and malaria. In 
southern China and Southeast Asia, the traditional practice of raising chickens 
and other birds in close proximity to family homes and selling them live in wet 
markets has been shown to play an important role in the emergence of new 
influenza strains.  
Transport influences health because the quality of roads can hasten or impede 
access to health facilities; the increase in the incidence of road traffic accidents in 
many low-income countries puts an additional strain on health facilities; and air 
pollution caused by vehicular emissions can have adverse health effects on 
children and adults.2  
Housing and home energy is another area that can affect health. Indoor air 
pollution, for example, can increase the risk of acute respiratory infections 
particularly in children as a result of the fuels used for cooking and heating.  
The education system also has a major influence on health, both because 
education is associated with better health and because the education system 
provides the required skills to those who will go on to work in the health system.  
Clearly, the potential benefits of effective intersectoral cooperation for improving 
public health and meeting the MDGs are significant. The problem is this potential 
is not being realized. For example, the provision of improved energy efficient 
cooking stoves could reduce exposure to indoor air pollution and thus key 
respiratory infections, but progress has been slow, particularly in Africa. Part of 
the explanation: in most low- and middle-income countries, the Ministry of Health 
is weak compared with sectors like finance, trade, and defence; and health 
figures relatively low among national development priorities in competing for 
resources. In addition, there are significant barriers that prevent other sectors 
from taking on board and acting on health considerations.  
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What is known and what is not known? 
The effects of poverty levels and gender inequity on health and vice versa are 
well known. African women and girls may spend three hours a day fetching water 
using a third of their caloric intake for this purpose.3 Studies done in Bangladesh 
have documented how women-focused poverty alleviation programmes 
contributed to a measurable improvement in child survival.4  
Socioeconomic development activities for the poor such as women’s 
empowerment, micro-credit,5,6 and conditional cash transfers7 have been shown 
to prevent ill health and improve access to treatment in some circumstances. 
Creating opportunities for community health workers to earn additional income 
such as through micro-credit can contribute to  increased motivation.8  
In recent years there has been a much better understanding of the relative 
importance of different risk factors for health.2 Potential strategies to reduce risks 
may be delivered through a range of sectors. For example, the fortification of 
food staples with vitamin A in Central America has involved regular visits to sugar 
mills by inspectors and regular sampling and testing of sugar taken from mills, 
markets, and homes for vitamin A content.   
There has been limited research on the effects of intersectoral actions targeting 
key behaviours such as hand washing using soap. Little is known about the 
specific role of the health system in the development and implementation of 
health promotion campaigns and interventions. Very little is known about how 
ministries of health and health systems in low- and middle-income countries can 
best work with other sectors, including non-governmental bodies, industry, and 
communities (see also template on community involvement). 
 
What research is needed and how will it help? 
Many different types of research are needed on how the health system can more 
effectively involve other sectors in delivering on the MDGs and reaching other 
health goals. Some specific research questions are: 
• How can a Ministry of Health raise its political profile and that of the health 
sector in order to better integrate health dimensions into social and 
economic policy? 
• How can a Ministry of Health at the national and local level engage other 
sectors to consider health outcomes—for example, the Ministry of 
Agriculture to provide access to essential foods and implement effective 
vector control programmes?  
• What is the most effective way to create the capacity for sustainable 
intersectoral action at international, regional, national, and local levels?  
• How can health data and information, such as projections on how the 
burden of disease will affect the health system, be used to influence 
policies across a range of sectors? 
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• How can effective interventions to promote healthy behaviours or reduce 
risk taking be delivered through other sectors including the mass media 
and schools? Where randomized trials are impossible or inappropriate (for 
example, nationwide media campaigns) what are the appropriate methods 
of evaluation?  
A better understanding is needed about the incentives and disincentives for 
policy makers outside the health sector to engage in health. This knowledge is 
important to consider when informing them about how their actions can make a 
significant difference to the health of the people they serve, and how the 
beneficial impacts can be multiplied with better planning and interactions with the 
health sector. Empirical work in low- and middle-income countries testing the 
impact of these and other development activities on health outcomes is needed.  
Research is also needed to evaluate the effectiveness of using health workers to 
promote and communicate intersectoral policies and strategies that affect health. 
Examples include improving access to clean water and sanitation, social 
marketing of insecticide-treated bednets, conditional cash transfers to enhance 
receipt of effective health interventions, and encouraging hand washing with 
soap through school-based programmes. In addition, the integration of the health 
system with other sectors and the role of the health sector in scaling-up other 
non-health sector interventions that may have an impact on health needs further 
evaluation.  
 
References 
1. For more information on this initiative see www.who.int/social_determinants. 
2. WHO. World Health Report 2002—reducing risks, promoting healthy life. 
Geneva: World Health Organization, 2002. 
3. UNDP. Human development report 2003. Oxford and New York: Oxford 
University Press, 2003.  
4. Bhuiya A, Chowdhury AMR. Beneficial effects of a women-focused 
development programme on child survival: evidence from Bangladesh. Social 
Science and Medicine 2002; 55: 1553–60.  
5. Gbezo BE, Microcredit in West Africa: how small loans make a big impact on 
poverty. World Work 1999; 31: 13–15.  
6. Chowdhury AMR, Mosley P, Anton Simanowit. The social impact of 
microfinance: Introduction. Special issue of Journal of International 
Development 2004; 16: 290–300. 
7. Rivera JA, Sotres-Alvarez D, Habicht JP, Shamah T, Villalpando S. Impact of 
the Mexican program for education, health, and nutrition (Progresa) on rates 
of growth and anemia in infants and young children: a randomized 
effectiveness study. JAMA 2004; 291: 2563–70. 
Report of the Task Force on Health Systems Research 60
8. Chowdhury AMR, Chowdhury S, Islam MN, Islam A, Vaughan JP. Control of 
tuberculosis by community health workers in Bangladesh. Lancet 1997; 350: 
169–72.  
Report of the Task Force on Health Systems Research 61
Effects of global initiatives and policies (including trade, donors, 
international agencies) on health systems 
 
What is the problem and why is it important? 
Global factors are increasingly impinging on national health policies and systems. 
The General Agreement on Trade in Services (GATS), for example, regulates 
trade in services, potentially including health services.1,2 The policies of global 
institutions such as the World Bank, the International Monetary Fund, World 
Trade Organization (WTO), WHO, the Global Fund for AIDS, TB and Malaria, 
affect the development and performance of health systems in many countries. 
Conditions laid down by large donors, such as the US Government's Millennium 
Challenge Account and the UK Chancellor of the Exchequer's proposed 
International Finance Facility, could also affect health. This influence is exerted 
both as a result of the flows of financial resources and because, in some cases, 
global institutions have a pivotal role in determining disease priorities and policies 
for health systems. The absorptive capacity of countries to use donor resources 
effectively and to coordinate the inputs of multiple donor agencies may be a key 
limiting factor in developing functioning health systems. 
Policies concerning trade can also have an impact on the determinants of health 
and the burdens on health systems. The health sector can be affected not only 
by trade in health services per se, but also by trade in services related to health 
(utilities, education, finance, advertising, etc). International trade in services is 
growing (60% of global production and employment; 20% of total trade), and 
health service-related sectors are being considered for trade liberalization under 
ongoing GATS negotiations. As a result, ministries of health are increasingly 
being requested by their trade counterparts to provide evidence of the potential 
impacts of liberalization on health systems and the overall economy. The 
problem is that there is so little evidence that can be used to shape 
macroeconomic policies and trade relations.  
The tobacco industry, which is expanding its penetration into low- and middle-
income countries, warrants special attention. The consumption of tobacco 
products is responsible for around five million deaths annually, around half of 
these in developing countries.3 But the capacity for effective tobacco control is 
lacking in many countries and civil society has not mobilized around the issue. 
This means that tobacco companies may be able to undermine attempts, for 
example, to impose restrictions on smoking in public places and impose taxes. 
    
What is known and what is not known? 
In the early 1990s, the Pan American Health Organization (PAHO) and the 
United Nations Conference on Trade and Development (UNCTAD) began to 
assess trends in the trade of health services. A five-country study led to 
guidelines for policy making by the health sector and foreign trade leaders.4 
PAHO followed with two studies on the health implications of the North American 
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Free Trade Agreement,5 which found private health insurance growing in Mexico, 
with some US investment. WHO in collaboration with other institutions is 
supporting country studies to analyse the health implications of trade 
liberalization and WTO rules.1
GATS has identified four modes of supplying services: 
1. Service flows from one country to another. For example, Indian companies 
transcribe medical records and send the information to US health facilities via 
direct satellite link. 
2. A consumer of a service travels to another country to obtain a service. For 
example, Bangkok and Singapore are drawing health consumers from the 
Asian region for specialized services unavailable in low-income countries and 
“health tourism” packages are attracting people from high-income countries. 
3. A service supplier in one country establishes a presence (through ownership 
or lease of premises) in another country to provide a service. For example, 
foreign investors and owners are increasingly entering health insurance 
markets in developing countries. By mid-1999, US health insurers had 
enrolled over five million members in Latin America. Chilean and Colombian 
private health insurance plans are rapidly entering foreign markets.6 
4. Persons from one country supply a service in another country. For example, 
Bangladesh, India, Pakistan, and the Philippines, among others, “export” 
large numbers of health professionals (see also template on human 
resources at the national level). Recruitment campaigns by the Canada, UK, 
US, and other developed countries have increased in recent years. 
There is a varying degree of knowledge at present about each mode in relation to 
health services; very limited information is available for cross-national 
comparisons. GATS negotiations highlight the urgent need for better evidence of 
the potential benefits and costs to health systems of any commitments to 
opening up health services to increased trade. Given that trade in health services 
has the potential to widen inequities within and between countries, it is important 
to quantify any such impacts and to evaluate policies to reduce the adverse 
impacts. 
It is known that tobacco companies try to influence national governments through 
a range of approaches in order to advance their commercial interests. Increases 
in smoking particularly amongst women have been attributed to the marketing 
activities of transnational corporations in the former Soviet Union and a number 
of countries.7 Less is known about how to effectively counter their influence in 
order to reduce tobacco-related harms.  
Increased financial flows into health are being channelled through the Global 
Fund as well as through bilateral initiatives such as the US President’s 
Emergency Fund for AIDS Relief (PEPFAR). But the evaluation of these activities 
is still quite limited. Interim findings, based on interviews with 137 national-level 
respondents that track early implementation processes in four African countries, 
indicated a number of difficulties meeting Global Fund conditions for 
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performance-based disbursement. For example, ineffective country coordinating 
mechanisms (CCMs) and limited capacity of fund recipients—government and 
non-government—led to delays in payment of funds to implementing agencies.8  
Little is known about their impact at the national and local level not just on the 
diseases to which they are directed but also on the delivery of care for other 
conditions.  
 
What research is needed and how would it help? 
In terms of the influence of donor and international agencies: 
• Donor priorities may compete and in some cases conflict with each other, 
thus the impacts of multiple donors on national health policies and 
approaches to coordinating donor activities need evaluation including 
mechanisms such as basket funds and sector wide approaches. 
• Research on how large global initiatives like the Global Fund, PEPFAR, 
and other bilateral approaches to funding interventions for priority 
diseases affect health systems is needed. The impact of major funders of 
health systems such as the World Bank on policies and practice also 
requires evaluation.  
• The impact of trade in harmful products such as tobacco requires further 
research particularly with regard to how marketing of such products can 
subvert public-health goals and how the activities of such commercial 
interests can be effectively regulated. 
In terms of trade in health services, research is needed to: (a) measure the 
extent to which trade in health services is taking place by country, region, and 
internationally; (b) understand the implications of trade liberalization of health 
services for health systems in terms of access to health services, quality of care, 
and ultimately health outcomes; and (c) inform negotiations under GATS and 
health policy making for harnessing the potential benefits of trade in health 
services and mitigate the costs. 
The following are some priority research topics related to trade: 
• measures of health system "openness" to trade; 
• essential data on trade in health-related services; 
• methodologies and data on the impact of liberalizing health service-related 
sectors on health system performance (methodologies for impact 
assessment, transmission mechanisms); 
• implications of trade agreements (multilateral, regional, and bilateral) on 
health systems (frameworks for assessment, development of indicators for 
tracking and monitoring impacts, assessment of impact on poor and 
vulnerable groups, country studies to inform the negotiation process, best 
practices, etc); 
Report of the Task Force on Health Systems Research 64
• legal implications of GATS for health policy development and regulation; 
• institutional/governance changes needed at the national, regional, and 
international level to promote policy coherence between trade and health; 
and 
• management of the GATS negotiation process to ensure health concerns 
are reflected. 
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